Metoprolol succinate and Minitran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Metoprolol succinate (metoprolol succinate) and Minitran (nitroglycerin). Common drug interactions include constipation among females and affective disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Metoprolol succinate and Minitran. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Metoprolol succinate?

Metoprolol succinate has active ingredients of metoprolol succinate. It is often used in high blood pressure. eHealthMe is studying from 66,933 Metoprolol succinate users. Check the latest studies of Metoprolol succinate.

What is Minitran?

Minitran has active ingredients of nitroglycerin. eHealthMe is studying from 950 Minitran users. Check the latest studies of Minitran.



On Aug, 09, 2026

12 people who take Metoprolol succinate and Minitran together, and have interactions are studied.

Metoprolol succinate and Minitran drug interactions.

What are the common drug interactions of Metoprolol Succinate and Minitran, by gender? *:

female:

  1. Constipation
  2. Decreased appetite
  3. Diarrhoea
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Gastritis (inflammation of stomach)
  6. Productive cough
  7. Pulmonary congestion (congestion in the lungs)
  8. Blood creatinine increased
  9. Blood urea increased
  10. Confusional state

male:

  1. Affective disorder (mental disorder)
  2. Anaemia (lack of blood)
  3. Blood immunoglobulin a increased
  4. Bone fistula
  5. Bone pain
  6. Breast pain
  7. Breast swelling
  8. Cachexia (loss of weight)
  9. Cardiomegaly (increased size of heart than normal)
  10. Cataract (clouding of the lens inside the eye)

What are the common drug interactions of Metoprolol Succinate and Minitran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Decreased appetite
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Headache (pain in head)
  4. Productive cough
  5. Pulmonary congestion (congestion in the lungs)
  6. Affective disorder (mental disorder)
  7. Anaemia (lack of blood)
  8. Anxiety
  9. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  10. Aphasia (damage to the parts of the brain that control language)

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 4 people, 33.33%
  2. Stable Angina (a constant chest pain): 2 people, 16.67%
  3. Oesophageal Carcinoma (cancer tumour of oesophagus): 2 people, 16.67%
  4. High Blood Cholesterol: 2 people, 16.67%
  5. Gastritis (inflammation of stomach): 2 people, 16.67%
  6. Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 16.67%
  7. Diabetes: 2 people, 16.67%
  8. Coronary Artery Insufficiency (insufficiency of artery to carry blood to heart): 2 people, 16.67%
  9. Cardiac Failure Congestive: 2 people, 16.67%
  10. Cardiac Disorder: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Metoprolol succinate and Minitran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Metoprolol succinate and Minitran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Metoprolol succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Minitran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Metoprolol succinate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Minitran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol succinate and nitroglycerin (the active ingredients of Metoprolol succinate and Minitran, respectively), and Metoprolol succinate and Minitran (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: